EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

33 hedge funds and large institutions have $54.4M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.48M
2
+$880K
3
+$611K
4
Deutsche Bank
Deutsche Bank
Germany
+$464K
5
TCM
Tekla Capital Management
Massachusetts
+$341K

Top Sellers

1
-$1.44M
2
-$711K
3
-$482K
4
DCM
DAFNA Capital Management
California
-$284K
5
Goldman Sachs
Goldman Sachs
New York
-$272K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11K
27
$7K
28
$7K
29
$2K
30
$1K
31
$693
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2